|
Bacillus anthracis
was the first bacterium proven by Robert Koch to cause diseases (anthrax). Koch formulated a criteria, today known as Koch's postulates, proving that a specific disease is caused by a specific microbe.
1. |
Organism found in diseased animal. |
2. |
Make a pure culture of that organism. |
3. |
Inoculate into healthy animal and it should develop disease symptoms. |
4. |
Re-isolate the organism from the experimental animal. |
5. |
Develop pure culture. |
Top
Bacillus anthracis |
Description |
Morphology |
Rod shape |
Gram Reaction |
Gram Positive (purple) |
Size |
1 - 1.5 m m x 4 - 10 m m |
Culture medium |
Ordinary nutrient medium |
Oxygen Requirement |
Aerobic or Facultative anaerobe |
Presence of Endospores |
Endospores present |
Habitat |
Soil |
Bacillus anthracis
causes the fatal disease Anthrax both in humans and animals.Anthrax is an acute infectious disease caused by Bacillus anthracis. It is usually a disease of domesticated and wild animals. Humans become infected when brought into contact with diseased animals and their products such as hides, bristles, or wool. It is common in essentially all areas where livestock are raised.
Top
Humans become infected by coming into contact with the spores (offspring of the microbe, can survive in soil for years), through 3 ways:
1. Skin (cutaneous)
A minor scratch or abrasion, usually on an exposed area is inoculated by spores from the soil or a contaminated animal or carcass. The spores germinate, vegetative cells multiply fast, and a characteristic gelatinous edema develops at the site.
This develop into papule within 12-36 hours after infection. The papule changes rapidly to a vesicle, then a pustule, and finally into a necrotic ulcer from which infection may disseminate, giving rise to septicemia. Lymphatic swelling also occurs within seven days. In severe cases, where the blood stream is eventually invaded, the disease is frequently fatal.
Itching at the site of infection, followed by formation of lesion (ulcer) with a black, necrotic (dying tissue) eschar (scab). About 20% of untreated cases of cutaneous anthrax will result in death.
2. Gastointestinal
Anthrax can be spread by eating undercooked meat from infected animal. This consumption is characterized by an acute inflammation of the intestinal tract. Initial signs of nausea, loss of appetite, vomiting, fever are followed by abdominal pain, vomiting of blood, and severe diarrhea. Intestinal anthrax results in death in 25% to 60% of cases.
3. Respiratory tract (Inhalation)
Inhalation anthrax, or Woolsorter's disease, which results most commonly from inhalation of dust where animal hair or hides are being handled.
Initial symptoms are low grade fever, a dry cough, and weakness, resembling a common cold.. The person may briefly improve after 2 - 4 days, but within 24 hours respiratory distress occurs with shock and death following shortly thereafter.
One component of the anthrax toxin has a lethal mode of the action that is not understood at this time. Death is apparently due to oxygen depletion, secondary shock, increased vascular permeability, respiratory failure and cardiac failure and frequently occurs suddenly and unexpectedly. The level of the lethal toxin in the circulation increases rapidly quite late in the disease, and it closely parallels the concentration of organisms in the blood.
Top
Anthrax is diagnosed by isolating B. anthracis from the blood, skin lesions, or respiratory secretions or by measuring specific antibodies in the blood of suspected cases.
Doctors usually prescribe effective antibiotics like penicillin, erythromycin, tetracycline, and chloramphenicol. To be effective, treatment should be initiated early. If left untreated, the disease can be fatal.
The anthrax vaccine for humans licensed for use is a cell-free filtrate vaccine, which means it uses dead bacteria as opposed to live bacteria. It is usually for individuals who come in contact in the workplace with imported animal hides, furs, wool, animal hair, bristles, etc; and for individuals engaged in diagnostic or investigational actives which my bring them into contact with anthrax spores.
Human anthrax vaccine was developed in England and the U.S. in the 1950s and early 1960s. The vaccine is U.S. Food and Drug Administration (FDA)-licensed and has been routinely given in the U.S. since 1970. The current dose schedule for the U.S. vaccine consists of 6 shots given over an 18 month schedule and an annual booster thereafter. The vaccine has an excellent safety record:
Since 1971, the FDA has received only 1 report of an adverse reaction, and this reaction was attributed to the use of dirty needle used to inject the vaccine. The reaction was an infection at the injection site.
The most common side effects reported are:
mild discomfort (localized swelling and redness at the site of injection), joint aches, and in a few cases, nausea, loss of appetite, and headaches. There is no evidence from records at the Michigan Biologic Products Institute (which is the only U.S. producer of the vaccine) that the vaccine is associated with permanent local or systemic effects.
Most people experience more side effects with the flu shot than to the anthrax vaccine.
Top
Anthrax as a Biological Warfare Agent
· Highly lethal |
® |
100 million lethal doses/gm of anthrax material |
|||
|
® |
silent, invisible killer |
|||
|
® |
Inhalational anthrax is virtually always fatal |
|||
· Low cost of production |
® |
Easy to produce in large quantities |
|||
· Easy to weaponize |
® |
Stable |
|||
|
® |
stored as dry powder; loaded in freeze-dried condition, in munitions or disseminated as an aerosol with crude sprayers. |
Top
Main | Synchromnium | Unicorn | Dexter | Fyche | Links | Profile | View Guestbook | Sign Guestbook